Just a few weeks ago, Boston Scientific announced that federal regulators issued marketing approvals for two defibrillators and a patient-monitoring system. At the same time, just a few days later it was announced that US Justice Department officials were conducting a civil investigation of Boston Scientific and other companies involving their sale of bile-duct stents.

Boston Scientific Corp. reported in a recent regulatory filing that the investigation is looking at whether they and other competitors promoted the sale of stents for non-FDA approved indications. The company is cooperating and no subpoenas have been filed according to Bloomberg News.

More Industry Headlines